Chemoinformaics analysis of 1-Propanamine (CAS) n-Propylamine
| Molecular Weight | 89.138 | nRot | 3 |
| Heavy Atom Molecular Weight | 78.05 | nRig | 0 |
| Exact Molecular Weight | 89.0841 | nRing | 0 |
| Solubility: LogS | 1.134 | nHRing | 0 |
| Solubility: LogP | -0.56 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 15.9167 |
| nHD | 1 | BPOL | 12.2013 |
| QED | 0.493 |
| Synth | 1.938 |
| Natural Product Likeliness | 0.314 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.027 |
| HIA | 0.011 |
| CACO-2 | -5.011 |
| MDCK | 0.000518088 |
| BBB | 0.348 |
| PPB | 0.0595949 |
| VDSS | 1.06 |
| FU | 0.903987 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.532 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.707 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.147 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.59 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.259 |
| CL | 6.219 |
| T12 | 0.508 |
| hERG | 0.036 |
| Ames | 0.067 |
| ROA | 0.573 |
| SkinSen | 0.715 |
| Carcinogencity | 0.496 |
| EI | 0.411 |
| Respiratory | 0.89 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.958947 |